Dokter MRI otak terbaik di luar negeri — Halaman 7

Dr. Mustafa Serkan Alemdar adalah onkolog klinis di Medical Park Antalya Hospital Complex. Beliau berspesialisasi dalam menangani tumor padat yang kompleks dan kanker darah. Dr. Alemdar menyelesaikan gelar kedokteran dan fellowship onkologinya di Universitas Akdeniz. Beliau adalah anggota aktif dari Turkish Society of Medical Oncology.

• Menangani berbagai jenis kanker termasuk kanker payudara, paru-paru, dan prostat.
• Pakar hematologi-onkologi untuk kondisi seperti leukemia, mieloma, dan limfoma.
• Melakukan terapi sistemik seperti kemoterapi, imunoterapi, dan terapi biologis target.
• Bekerja di fasilitas yang memiliki unit onkologi-sumsum tulang khusus dan teknologi LINAC.

Dr. Halil Gulluoglu adalah seorang ahli saraf di Medicalpoint International Hospital di Izmir. Beliau menangani kondisi neurologis yang kompleks termasuk epilepsi, demensia tipe Alzheimer, dan penyakit serebrovaskular. Dr. Gulluoglu sebelumnya menjabat sebagai Asisten Profesor di Universitas Canakkale 18 Maret.

• Spesialis dalam perawatan migrain, termasuk suntikan Botox dan vaksin migrain.
• Anggota aktif Asosiasi Neurologi Turki.
• Pakar dalam menangani gangguan gerak, miopati, dan penyakit demielinasi.
• Bekerja di fasilitas terakreditasi JCI yang memegang sertifikasi ISO, EFQM, dan TEMOS.

Profesor Yan Zhi Ping memimpin Departemen Radiologi di Xiamen Humanity Hospital. Beliau berspesialisasi dalam diagnosis tumor otak dan pencitraan fungsional serebral.

• Melakukan penelitian ekstensif tentang pencitraan MRI dan CT sistem saraf pusat
• Menerbitkan lebih dari 30 makalah akademik tentang pencitraan diagnostik tingkat lanjut
• Menjabat sebagai Wakil Ketua Masyarakat Radiologi Xiamen
• Pakar dalam mengidentifikasi dan membedakan berbagai jenis tumor otak
• Menerima penghargaan untuk kemajuan ilmu pengetahuan dan teknologi di tingkat provinsi dan kota

Dr. Mehmet Hakan Şahin adalah seorang dokter spesialis bedah saraf di Atlas University Hospital (per tahun 2026). Beliau memiliki spesialisasi dalam bedah neuro-onkologi dan bedah neurovaskular. Beliau juga menangani bedah dasar tengkorak (skull base), bedah kranial kompleks, dan bedah tulang belakang. Beliau pernah menjabat sebagai Asisten Profesor di Universitas Atatürk (2019–2024) dan bertugas di UW Health (2024–2025).

Beliau telah mempublikasikan 29 artikel ilmiah internasional yang telah ditinjau oleh sejawat (peer-reviewed) dan 11 artikel nasional. Beliau telah menulis 5 bab buku teks kedokteran. Beliau telah memberikan 7 presentasi lisan, termasuk pada AANS 2025 dan panel tahun 2024 mengenai reseksi glioma supratotal. Penghargaan yang beliau terima meliputi Turkish Neurosurgery Association Young Neurosurgeon Incentive Award 2024 (Juara Kedua) dan Juara 1 pada 1st Yaşargil Microneurosurgery Academy. Beliau memegang Sertifikat Kualifikasi Bedah Saraf Turki (2023). Beliau telah menjadi anggota Turkish Neurosurgery Association sejak tahun 2017 (No. 1620).

Dr. Muhammed Mustafa Atci adalah Profesor Madya Onkologi Medis di Liv Hospital Topkapı. Beliau berspesialisasi dalam pengobatan kanker usus besar, payudara, lambung, dan paru-paru. Sebelumnya, beliau menjabat sebagai Koordinator Pendidikan di Rumah Sakit Kota Prof. Dr. Cemil Taşcıoğlu. Dr. Atci adalah anggota American Society of Clinical Oncology (ASCO).

• Penulis 19 makalah yang ditinjau sejawat tentang kanker gastrointestinal, toraks, dan endokrin.
• Menerbitkan studi tentang hasil kelangsungan hidup untuk kanker usus besar stadium IIB di Journal of Chemotherapy.
• Meneliti biomarker prognostik menggunakan pemindaian PET/CT dan volume tumor metabolik.
• Menangani kasus onkologi kompleks di klinik universitas İstinye University.

Dokter ini adalah ahli saraf terkemuka dan peneliti utama dalam 100 uji klinis, dengan fokus khusus pada sklerosis ganda, penyakit Parkinson, Alzheimer, dan sklerosis lateral amiotrofik. Spesialis ini menggunakan intervensi terapeutik canggih, termasuk plasmaferesis dan teknologi neurorehabilitasi seperti eksoskeleton.

Dengan karier yang mencakup peran kepemimpinan sebagai Kepala Neurologi di rumah sakit universitas besar, dokter ini memegang akreditasi sebagai Profesor Ilmu Kedokteran. Sebagai peneliti yang ulung, spesialis ini telah menulis lebih dari 400 karya ilmiah, termasuk 139 artikel internasional yang dikutip lebih dari 4.500 kali, dan telah memimpin berbagai proyek penelitian yang didanai oleh Institut Kesehatan Carlos III.

Dr. Fatma Gulhan Sahbaz adalah seorang ahli saraf di Medicalpoint International Hospital di Izmir. Beliau adalah mantan Kepala Klinik di Rumah Sakit Negara Afyonkarahisar. Dr. Sahbaz berfokus pada gangguan gerak, intervensi stroke, dan epilepsi. Beliau menangani penyakit neurodegeneratif kompleks seperti Alzheimer dan ALS.

• Anggota International Parkinson and Movement Disorder Society.
• Merawat pasien menggunakan stimulasi otak dalam dan pompa apomorfin.
• Melakukan blok saraf oksipital besar untuk manajemen sakit kepala kronis.
• Berpraktik di Medicalpoint International Hospital yang terakreditasi JCI.

Dr. Evren Sandal adalah ahli bedah saraf di Medicalpoint International Hospital di Izmir. Beliau berspesialisasi dalam bedah dasar tengkorak, bedah saraf vaskular, dan bedah persimpangan kranioservikal. Dr. Sandal menyelesaikan penelitian terfokus dalam bedah bypass serebral di University of Wisconsin, AS. Beliau menangani kondisi kompleks termasuk tumor otak, stenosis tulang belakang, dan kista otak.

• Terlatih dalam bedah dasar tengkorak di pusat medis universitas terkemuka di AS.
• Melakukan prosedur khusus seperti diskektomi dan stimulasi otak dalam (DBS).
• Berkolaborasi dengan pakar global dalam teknik persimpangan kranioservikal dan bypass serebral.
• Bekerja di Medicalpoint Hospital yang terakreditasi JCI, yang memiliki Pusat Bedah Robotik khusus.

Dr. Lee Sanggu, MD, PhD, adalah seorang ahli bedah saraf. Beliau adalah Direktur Medis Kehormatan dan Direktur Pusat Tulang Belakang. Beliau juga merupakan Profesor Bedah Saraf di Gachon University Gil Medical Center.

Fokus klinis meliputi tumor tulang belakang, gangguan tulang belakang, bedah tulang belakang invasif minimal, dan gangguan servikal. Prosedur yang dilakukan meliputi PEN, PNP, blok saraf selektif, diskektomi mikroskopis atau endoskopis, penggantian cakram buatan, fusi tulang belakang invasif minimal, dan vertebroplasti.

Beliau meraih gelar PhD di bidang Kedokteran dari Universitas Hanyang. Beliau pernah menjabat sebagai Kepala Bedah Saraf di Veterans Health Service Medical Center. Beliau adalah anggota dewan eksekutif KNS, KNTS, dan KSNS. Beliau pernah menjabat sebagai Wakil Presiden dan Presiden KSCS. Beliau adalah mantan presiden KOMISS, KAME, dan KSPNS. Beliau adalah anggota Komite AOSpine Asia Pasifik dan anggota penuh NASS. Beliau tercantum dalam Marquis Who’s Who pada tahun 2010.

Dr. Han Yeongmin adalah seorang ahli bedah saraf (MD, PhD). Beliau adalah Direktur Medis dan Direktur Pusat Bedah Saraf di Rumah Sakit St. Mary Incheon. Beliau menangani penyakit serebrovaskular dan gangguan saraf tepi. Beliau juga memiliki spesialisasi dalam tumor otak dan bedah dasar tengkorak. Kondisi yang ditangani meliputi stroke, perdarahan otak, infark otak, dan penyakit moyamoya. Beliau melakukan prosedur PEN, PNP, dan SNB. Beliau juga menawarkan diskektomi mikroskopis dan endoskopi, penggantian cakram buatan, MIS-TLIF/fusi tulang belakang minimal invasif, dan vertebroplasti.

Beliau meraih gelar MD dan PhD dari Universitas Katolik Korea. Beliau pernah menjabat sebagai profesor tamu dalam bedah serebrovaskular dan dasar tengkorak di Barrow Neurological Institute (Phoenix, Arizona, AS). Beliau juga pernah bertugas di Harborview Medical Center, Universitas Washington (Seattle, AS).

Publikasi beliau mencakup penulisan bersama Bab 52 dari Buku Teks Bedah Serebrovaskular Korea. Beliau juga merupakan rekan penulis Acoustic Neuroma Oncology. Beliau adalah anggota penuh KNS, KSCVS, KSBS, KBTS, KNTS, KSNS, dan KSPNS.

Dr. Ali Osman Mucuoglu adalah ahli bedah saraf di Rumah Sakit Universitas Atlas di Istanbul. Beliau berspesialisasi dalam pengangkatan tumor otak dan bedah minimal invasif untuk perdarahan intraserebral. Dr. Mucuoglu menggunakan teknologi pencetakan 3D untuk hipofisektomi transfenoidal berbantuan. Beliau adalah anggota Asosiasi Masyarakat Bedah Saraf Eropa.

• Menyelesaikan pelatihan bedah saraf di Universitas Dokuz Eylül.
• Menangani kondisi kompleks termasuk stenosis tulang belakang, spondilolistesis, dan neuroma akustik.
• Melakukan bedah stimulasi otak dalam (DBS) dan stimulasi saraf vagus.
• Berspesialisasi dalam neuroanatomi bedah dan manajemen cedera kepala.

Dr. Jesus Romero Imbroda adalah seorang ahli saraf di Quirónsalud Marbella. Beliau adalah Fellow dari European Board of Neurology. Dr. Romero Imbroda menjabat sebagai akademisi di Royal Academy of Medicine. Beliau berfokus pada penelitian sklerosis ganda dan gangguan neuromuskular yang kompleks. Dokter ini juga mengajar di Universitas Granada.

• Mantan Presiden Masyarakat Neurologi Andalusia.
• Pernah bertugas di Komite Penilaian Dokter Residen Internal.
• Menangani penyakit Parkinson, epilepsi, dan kondisi kognitif.
• Melakukan prosedur stimulasi otak dalam dan stimulasi sumsum tulang belakang.

Dr. Tuncay Kaner adalah ahli bedah saraf tulang belakang di Rumah Sakit Medical Park Bahcelievler. Beliau menyelesaikan fellowship di UCLA Santa Monica Comprehensive Spine Center. Dr. Kaner adalah anggota aktif Scoliosis Research Society (SRS). Beliau juga merupakan anggota AO Spine International. Beliau bertugas di rumah sakit universitas terakreditasi JCI di Istanbul.

• Spesialis dalam diskektomi endoskopi dan bedah fusi invasif minimal.
• Pernah menjadi dosen tamu di University of Virginia.
• Menangani stenosis tulang belakang yang kompleks, tumor otak, dan saraf terjepit (HNP).
• Anggota Society for Minimal Intervention in Spinal Surgery.

Dr. Halil Can adalah Profesor Bedah Saraf di Rumah Sakit İstinye University Liv Topkapı. Beliau berspesialisasi dalam bedah tulang belakang endoskopi dan bedah mikro untuk tumor dan penyakit degeneratif. Dr. Can adalah penulis dari 21 publikasi internasional yang ditinjau oleh rekan sejawat. Beliau melakukan prosedur kompleks termasuk bedah endoskopi dasar tengkorak dan kelenjar hipofisis.

• Melakukan uji keamanan Fase I untuk perawatan sel punca pada cedera sumsum tulang belakang.
• Melaporkan hasil bedah untuk 81 kasus aneurisma sirkulasi posterior.
• Pakar dalam manajemen nyeri tingkat lanjut seperti terapi ozon intradiskal dan nukleoplasti laser.
• Melakukan bedah saraf fungsional termasuk bedah Parkinson dan implantasi stimulator sumsum tulang belakang.

Dr. Tara Rak-areekul adalah seorang ahli saraf di PYONG Rehabilitation Group di Bangkok. Beliau meraih peringkat pertama dalam ujian neurologi nasional Thailand untuk residen dan rekan sejawat. Dr. Rak-areekul berfokus pada neurologi kognitif dan gangguan neurodegeneratif seperti penyakit Alzheimer dan Parkinson. Beliau memiliki sertifikasi dalam NIHSS dan pengobatan stroke akut.

• Menggunakan stimulasi magnetik transkranial (TMS) untuk pemulihan neurologis.
• Memenangkan turnamen kuis epilepsi nasional selama pelatihan spesialisnya.
• Meneliti biomarker Alzheimer dan fungsi kognitif di Rumah Sakit King Chulalongkorn Memorial.
• Pendiri CUMEMO, sebuah platform digital untuk pencegahan demensia dan edukasi.

Dr. Naphat Sirinimnualkul adalah psikiater dan instruktur klinis di King Chulalongkorn Memorial Hospital. Beliau berspesialisasi dalam persimpangan antara gangguan tidur dan kondisi psikiatri. Dr. Sirinimnualkul berfokus pada kedokteran tidur, neuropsikiatri, dan psikofarmakologi. Beliau berpraktik di PYONG Rehabilitation Group di Bangkok.

• Meraih gelar Dokter Kedokteran dengan penghargaan kelas dua dari Universitas Chulalongkorn.
• Menyelesaikan pelatihan khusus dalam Terapi Perilaku Kognitif untuk Insomnia.
• Menangani kondisi kompleks termasuk gangguan suasana hati, depresi, dan skizofrenia.
• Bekerja di klinik yang dilisensikan oleh Dewan Medis Thailand.

Dr. Somjet Tosamran adalah seorang ahli saraf di PYONG Rehabilitation Group di Bangkok. Beliau meraih gelar kedokteran dengan predikat First Class Honors dari Universitas Chulalongkorn. Saat ini, Dr. Tosamran sedang menjalani fellowship epilepsi di King Chulalongkorn Memorial Hospital. Beliau berfokus pada gangguan kejang kompleks dan kondisi neurodegeneratif.

• Spesialis dalam pengobatan epilepsi, penyakit Parkinson, dan Alzheimer.
• Menggunakan stimulasi magnetik transkranial (TMS) untuk pemulihan neurologis.
• Melakukan manajemen pengobatan untuk nyeri kronis dan komplikasi stroke.
• Memiliki gelar Master of Science dalam Penyakit Dalam dari Universitas Chulalongkorn.

Dr. Shady Mohammed El-sebai adalah Kepala Radiologi Intervensional di National Cancer Institute, Universitas Kairo. Beliau berspesialisasi dalam pencitraan onkologi dan prosedur invasif minimal. Dr. El-sebai menangani tumor hati, ginjal, dan jaringan lunak menggunakan teknik kemoembolisasi dan ablasi. Beliau bekerja di Rumah Sakit Onkologi Shef Al Orman, sebuah pusat yang terakreditasi ESMO.

• Melakukan ablasi gelombang mikro dan frekuensi radio untuk lesi tulang, paru-paru, dan tiroid.
• Pakar dalam biopsi yang dipandu USG dan CT, termasuk eksisi lesi payudara dengan Mammotome.
• Berspesialisasi dalam embolisasi arteri rahim untuk fibroid dan ablasi varises.
• Menangani kasus bilier dan ginjal yang kompleks dengan pemasangan stent perkutan dan drainase.

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.